{"id":3074,"date":"2025-03-04T15:58:05","date_gmt":"2025-03-04T12:58:05","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=3074"},"modified":"2025-03-07T12:54:37","modified_gmt":"2025-03-07T09:54:37","slug":"capricor-therapeutics-announces-fda-acceptance-for-deramiocel-to-treat-duchenne-muscular-dystrophy","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/de\/capricor-therapeutics-announces-fda-acceptance-for-deramiocel-to-treat-duchenne-muscular-dystrophy\/","title":{"rendered":"Capricor Therapeutics gibt Annahme und vorrangige Pr\u00fcfung seines Zulassungsantrags f\u00fcr FDA zur Behandlung der Duchenne-Muskeldystrophie bekannt"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Capricor Therapeutics, a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced the U.S. Food and Drug Administration (\u201cFDA\u201d) has accepted for review its Biologics License Application (\u201cBLA\u201d) seeking full approval for deramiocel, an investigational cell therapy, as a treatment for patients diagnosed with Duchenne muscular dystrophy (\u201cDMD\u201d) cardiomyopathy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Additionally, the FDA granted the BLA Priority Review with a Prescription Drug User Fee Act (\u201cPDUFA\u201d) target action date of August 31, 2025 and at this time, the FDA has not identified any potential review issues. [<a href=\"https:\/\/dmdwarrior.com\/capricor-therapeutics-submits-application-for-treatment-of-dmd-cardiomyopathy\/\" target=\"_blank\" rel=\"noreferrer noopener\">About Deramiocel<\/a>]<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Capricor Therapeutics, a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced the U.S. Food and Drug Administration (\u201cFDA\u201d) has accepted for review its Biologics License Application (\u201cBLA\u201d) seeking full approval for deramiocel, an investigational cell therapy, as a treatment for patients diagnosed with Duchenne muscular dystrophy (\u201cDMD\u201d) [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3075,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[90,86,87,89,85,88],"class_list":["post-3074","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-cap-1002","tag-capricor","tag-capricor-therapeutics","tag-cardiomyopathy","tag-deramiocel","tag-fda"],"subtitle":"Heute gab Capricor Therapeutics bekannt, dass die US-amerikanische Gesundheitsbeh\u00f6rde FDA (\u201eFDA\u201c) seinen Biologics License Application (\u201eBLA\u201c) zur Pr\u00fcfung angenommen hat. Darin wird die vollst\u00e4ndige Zulassung von Deramiocel beantragt, einem experimentellen Zelltherapeutikum zur Behandlung der Kardiomyopathie der Muskeldystrophie Duchenne (\u201eDMD\u201c).","_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts\/3074","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/comments?post=3074"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts\/3074\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/media\/3075"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/media?parent=3074"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/categories?post=3074"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/tags?post=3074"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}